Lineage Cell Therapeutics
LCTX
LCTX
113 hedge funds and large institutions have $94.2M invested in Lineage Cell Therapeutics in 2024 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 35 increasing their positions, 26 reducing their positions, and 11 closing their positions.
Holders
113
Holders Change
-3
Holders Change %
-2.59%
% of All Funds
1.64%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
8
Increased
35
Reduced
26
Closed
11
Calls
$100K
Puts
–
Net Calls
+$100K
Net Calls Change
-$147K
Top Buyers
| 1 |
RA
1
Raffles Associates
New York
|
$4.35M |
| 2 |
2
BlackRock
New York
|
$9.53M |
| 3 |
3
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$646K |
| 4 |
4
State Street
Boston,
Massachusetts
|
$2.56M |
| 5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$3.59M |
